CIK 0001001316 · Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363898269
- Phone
- (212) 554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- S-1 Offering Registration Statement
- 8-K/A Event Acquisition or sale completed
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Other events
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 33 of 58 · 1,151 filings